- Biotechnology Innovator Specializing in AI Chatbot Solutions for Early Drug Discovery, Infectious Disease and Neurodegenerative Disease Research.
- Strong Progress in Q3 of 2024, Well Positioning CBDW in the AI Chatbot Market.
- Focus on Developing Therapeutic Solutions by Leveraging Human Immune-B Cells for a Cutting-Edge Approach to Highly Effective Treatments.
- Strategic Investment Plan Demonstrating Commitment to Advancing Technological Capabilities and Expanding Reach in the AI Sector.
- Plans to Attend IPO Summit 2025 on April 15 in New York.
- Expanding Markets and AI Collaborations in Biotech, Distribution and Waste Management via Partnerships for AI-Driven Customer Service and Tools.
- LOI Signed for Acquisition for $1 Million by Private Group Seeking to Enter the Public Markets and Utilize AI Technologies for Potential Uplisting.
- Launch of RedChat Validates the Success and Impact of Current CBDW AI-Driven IRChat Product.
- New Partnership with GPOPlus to Enhance AI-Driven Distribution Solutions.
- AI Platform Confirmed Decades of Work and Added New Targets for Monoclonal Antibodies with Independent Validation of Their Potential from Collaborators.
- Growing IP Portfolio Including Patents, Trademarks and Trade Secrets.
1606 Corp. (OTC: CBDW) stands at the forefront of technological innovation, particularly in AI Chatbots. The Company mission is to revolutionize customer service, addressing the most significant challenges faced by consumers in the digital marketplace. 1606 Corp. is dedicated to transforming the IR industry through cutting-edge AI centric solutions, ensuring a seamless and efficient customer experience.
1606 Corp (CBDW) is a leading innovator in biotechnology, specializing in AI-driven solutions for early drug discovery, infectious disease, and neurodegenerative disease research. Proprietary methods focus on developing therapeutic solutions by leveraging human immune-B cells, offering a cutting-edge approach to creating highly effective treatments.
CBDW Generative AI Chatbots can provide instant, round-the-clock support, guiding potential investors through the company. Queries about dosage, usage, legality, while offering personalized recommendations based on individual preferences. Moreover, CBDW chatbots can handle multiple interactions simultaneously, ensuring no potential or existing investor feels neglected due to long response times. They also collect valuable data on investor preferences and behaviors, allowing companies to tailor their communication strategies more effectively. In the investor relations industry, where transparency and timely information are paramount, CBDW chatbots can provide up-to-date details on earnings reports, stock performance and company news. This immediate access to information builds confidence with investors, encouraging them to make informed decisions.
The global artificial intelligence market has seen remarkable growth, valued at $428 billion in 2022 and projected to reach $2.25 trillion by 2030. With a compound annual growth rate (CAGR) ranging from 33.2% to 38.1%, AI's global impact is undeniable, with as many as 97 million individuals expected to work in the AI sector by 2025, according to fortunebusinessinsights.com.
Update on AI Chatbots Innovations, Strategic Partnerships and 2025 Outlook
On April 2nd CBDW provided an update on its strides to lead the AI-driven customer service and automation sectors.
CBDW announced plans to attend the highly anticipated IPO Summit 2025 on April 15 in New York. This prestigious event brings together industry leaders, investors, and key decision-makers to discuss the latest trends and opportunities in the public markets. CBDW is actively engaged in discussions with several companies regarding potential mergers and the opportunity to up-list to a major stock exchange.
Throughout Q4, CBDW made remarkable strides in enhancing its AI-powered chatbot solutions to develop advanced machine learning models and natural language processing techniques to provide businesses with highly personalized, human-like interactions. These innovations have positioned CBDW to tap into rapidly growing sectors such as e-commerce, finance, healthcare, and telecommunications.
A key milestone for Q4 was the advancement of several strategic partnerships aimed at expanding CBDW technological capabilities across a variety of industries in sectors such as waste management, distribution, biotech, and beyond.
CBDW Outlook for 2025 Includes:
Enhancing AI Solutions with new features and capabilities, addressing the growing demand for automation, customer service, and engagement tools.
Expanding markets and AI Collaborations in high-growth verticals such as Biotech, Distribution, and waste management through our partnerships, capitalizing on the increasing need for AI-driven customer service and operational tools.
CBDW anticipates that the growing adoption of AI-powered solutions like Chat IR will contribute to revenue growth, driven by increased demand for our innovative products and collaborations in a variety of industries.
LOI to Be Acquired by Private Group Seeking to Enter the Public Markets and Utilize AI Technologies for Potential Uplisting
On March 11th CBDW announced it has signed a non-binding Letter of Intent (LOI) with a private group led by Jon Garfield and Chuck Arnold which is focused on acquiring waste management companies, to acquire a controlling position in the Company for $1 million. It is anticipated that key management within CBDW will remain with the Company post-acquisition.
In addition to the purchase of a proposed controlling position in CBDW, Messrs. Arnold and Garfield have unveiled plans to begin acquiring waste management companies as part of their strategy to consolidate smaller firms within the market. This move aligns with their broader vision to expand into new markets and capitalize on the growing demand for sustainable and efficient waste management solutions. Existing CBDW AI solutions would also be leveraged to further enhance the waste management industry.
CBDW has developed a cutting-edge AI platform and launched successful applications across a range of industries, including CBD, public companies, and other verticals. The platform is now poised for expansion into the waste management sector, where we aim to pioneer new technologies for waste stream separation and the management of a nationwide fleet of trucks.
RedChip's Launch of RedChat Validates the Success and Impact of Current CBDW AI-Driven IRChat
On February 11th CBDW acknowledged the growing validation of chatbot technology in the small-cap investment space following the recent launch of RedChat by RedChip Companies. RedChip's introduction of RedChat, an AI-powered tool designed to provide instant insights into microcap and small-cap stocks, mirrors our own successful deployment of a similar chatbot over a year ago, further cementing the efficacy and demand for AI-driven investment research solutions.
RedChip's RedChat launch underscores the growing recognition of AI chatbots as tools for investors. This development validates the vision CBDW had for its own AI-powered chatbot in early 2024, providing investors with deep insights into thousands of publicly traded companies using real-time access to financial filings, press releases, and corporate disclosures.
Strategic Partnership with GPOPlus to Enhance AI-Driven Distribution Solutions
On February 4th1606 Corp. (CBDW) announced a new strategic partnership with GPO Plus, Inc. (OTCQB:GPOX), an AI-powered Distributor revolutionizing distribution to gas stations and convenience stores with its innovative technology-driven Direct Store Delivery (DSD) model. Under the terms of a new agreement, CBDW will provide AI-driven services to enhance the functionality, performance, and capabilities of GPOX's PRISM+ platform.
GPOX is known for its innovative technology-driven Direct Store Delivery (DSD) model, which leverages AI to optimize inventory management, streamline deliveries, and drive operational excellence for the convenience store and gas station industries. By further integrating advanced AI solutions, GPOX aims to take its PRISM+ platform to the next level, helping its clients make real-time data-driven decisions, improve customer satisfaction, and increase efficiency and profitability.
For more information on $CBDW visit: www.cbdw.ai and https://www.adnexusbiotech.com
DISCLAIMER: https://corporateads.com/disclaimer/
Disclosure listed on the CorporateAds website
Media Contact
Company Name: 1606 Corp.
Contact Person: Austen Lambrecht, CEO
Email: Send Email
Phone: (602) 481-1544
Address:2425 East Camelback Road Suite 150
City: Phoenix
State: AZ 8501
Country: United States
Website: https://www.adnexusbiotech.com
